Drug
Azd0543
Azd0543: highest development phase Phase 1, developed by AstraZeneca. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- AstraZeneca
Trials
| Drug | Phase | Indication |
|---|---|---|
| AZD0543 NCT07824622 | Phase 1 | Human Metapneumovirus Infection |
Latest
No recent events.
Follow Azd0543 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.